Chief Scientific Officer Stephen Betz sells 3,000 shares of Crinetics …
According to a recent SEC filing, Chief Scientific Officer Stephen Betz sold 3,000 shares of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) on August 12, 2024. Following this transaction, the insider now owns…
